Can you provide details on the prescription weight loss programs
About 10 patients for whom she has prescribed GLP-1s in the past two years have volunteered to her that the medicines have reduced their use of alcohol, she said
Separately, Foundayo (orforglipron) recently became the first non-peptide oral GLP-1 receptor agonist approved by the FDA
Support hydration, sleep and stress levels Poor sleep and high stress can affect appetite and weight
Unlike traditional diet methods that rely purely on willpower, semaglutide targets biological pathways that directly influence hunger, satiety, and calorie intake, making weight loss more attainable for many individuals
Currently, yes semaglutide has proven cardiovascular benefit from the SELECT trial (2023), which demonstrated significant reduction in major adverse cardiovascular events (heart attack, stroke, cardiovascular death) in patients with obesity and established heart disease